Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study
- 1 May 2006
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (7) , 895-904
- https://doi.org/10.1016/j.ejca.2005.12.013
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chemoendocrine Therapy for Premenopausal Women With Axillary Lymph Node–Positive, Steroid Hormone Receptor–Positive Breast Cancer: Results From INT 0101 (E5188)Journal of Clinical Oncology, 2005
- Adjuvant Chemotherapy Followed by Goserelin Versus Either Modality Alone for Premenopausal Lymph Node-Negative Breast Cancer: A Randomized TrialJNCI Journal of the National Cancer Institute, 2003
- Survival analyses from the ZEBRA studyEuropean Journal Of Cancer, 2003
- Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized StudyJournal of Clinical Oncology, 2003
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patientsEuropean Journal Of Cancer, 2000
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Epidemiology and Prevention of Breast CancerAnnual Review of Public Health, 1996